Sun Pharmaceutical Industries Ltd. closed 10.99% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

New Delhi: Sun Pharmaceutical Industries (Sun Pharma) has launched its corporate brand campaign, aiming to highlight its impact on the lives of people. Created by Ogilvy Mumbai, the campaign is ...

Sun Pharmaceutical Industries Ltd. closed 9.90% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Sun Pharmaceutical Industries Limited (Sun Pharma), India’s No. 1 pharma company by revenues and prescriptions has launched its corporate brand campaign that highlights its profound impact on the ...

Sun Pharma said it will disclose its launch plans in due course of time. Leqselvi or deuruxolitinib is used to treat alopecia areata, an auto-immune condition that causes hair-loss, and it affects ...

Additionally, MACD remains positive, supporting the bullish setup. After hitting a record high, Sun Pharma has witnessed a healthy rebound while consolidating within a wide trading range.

Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report. As per the ...

Garfunkel, one half of Rock and Roll Hall of Fame duo Simon & Garfunkel, is speaking out for the first time about living with psoriasis in Sun Pharma’s I LUV YA for The Long Haul campaign, which aims ...

As of 11:00:40 AM GMT+5:30. Market Open. On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint ...

Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report. As per the US ...

Benchmark indices, which opened slightly in the green, turned negative as pharma giants like Sun Pharma, Cipla, Lupin, and Aurobindo Pharma tumbled in early trade. Trump’s order seeks to fast ...

The US Court of Appeals has vacated the preliminary injunction against Sun Pharma’s launch of Leqselvi which was granted by the US District Court of New Jersey in Nov-24. While the decision of ...